Will Medline's Q4 Earnings Validate Its Prime Vendor Growth Strategy?

MDLN is set to report first earnings as a public company, with Prime Vendor growth and brand mix in focus ahead of Q4 results.

Zacks Investment Research • 5 hours ago

Biggest IPO In Years Is A Winner So Far, But This Key Test Looms

Medline, the nation's largest provider of medical supplies, will release its first post-IPO earnings report on Wednesday.

Investors Business Daily • Feb 19, 2026

Medline announces participation in the Barclays 28th Annual Global Healthcare Conference

NORTHFIELD, Ill., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that Jim Boyle, Chief Executive Officer, and Mike Drazin, Chief Financial Officer, are scheduled to present at the Barclays 28th Annual Global Healthcare Conference in Miami Beach, FL, on Wednesday, March 11, 2026, at 9:30am ET.

GlobeNewsWire • Feb 18, 2026

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio

Did you know that the largest initial public offering in 2025 was a boring medical supply company based in Chicago? Medline looks primed and ready to continue delivering on its history of rapid, profitable sales growth These 10 Stocks Could Mint the Next Wave of Millionaires ›

The Motley Fool • Feb 5, 2026

Medline to report fourth quarter and full year 2025 results on February 25, 2026

NORTHFIELD, Ill., Jan. 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (“Medline”) (Nasdaq: MDLN) today announced that it plans to report fourth quarter and full year 2025 financial results on Wednesday, February 25, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results.

GlobeNewsWire • Jan 28, 2026

Medline Industries: Solid Physical Moat With Visible Earnings Growth Runway

Medline Industries (MDLN) earns a buy rating due to its robust vertically integrated model and scale-driven logistics advantages. MDLN's private label strategy enables margin expansion as contract wins accelerate, with signed FY2025 Prime Vendor contracts already doubling historical run rates. The company's logistics moat and cross-selling drive a virtuous cycle of market share gains and higher profitability, supporting durable growth.

Seeking Alpha • Jan 21, 2026

Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Medline Inc. (MDLN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Seeking Alpha • Jan 14, 2026

Analysts initiate Medline with bullish ratings after blockbuster IPO

Brokerages began coverage of Medline with largely bullish ratings on Monday, betting on supply chain strength and brand penetration, following the firm's upsized U.S. initial public offering in December - the biggest globally in 2025.

Reuters • Jan 12, 2026

Analysts Say Medline Has The Secret Sauce For Sustained Growth

Several analysts initiated coverage on Medline Inc. (NASDAQ: MDLN) on Monday, one of the largest providers of medical-surgical products and supply chain solutions.

Benzinga • Jan 12, 2026

The Biggest IPO of the Year Prompts Huge Insider Buy

As the year winds down, many investors are positioning themselves for 2026 and beyond.

24/7 Wall Street • Dec 30, 2025